Tensha Therapeutics Director of Finance Salaries in Albuquerque, NM | Comparably
Tensha Therapeutics develops small molecule bromodomain inhibitors to treat cancer and other serious disorders. read more
EMPLOYEE
PARTICIPANTS
3
TOTAL
RATINGS
102

Tensha Therapeutics Director of Finance Salaries in Albuquerque, NM

The average Tensha Therapeutics Director of Finance in Albuquerque, NM earns an estimated $147,753 annually. Tensha Therapeutics' Director of Finance compensation is $14,263 less than the US average for a Director of Finance.

In Albuquerque, NM, The Finance Department at Tensha Therapeutics earns $14,856 more on average than the Customer Support Department.

Last updated 5 years ago.

$30k
$74k
$117k
$159k
$350k
$600k
$147,753
Average Compensation
$147,753
avg. base

Director of Finance Salaries at Tensha Therapeutics

In Albuquerque, NM, Directors of Finance earn $28,149 more than Business Analysts.

Business Analyst
$120k*
Accounting Manager
$115k*
Senior Accountant
$92k*
Financial Analyst
$87k*
Accountant
$67k*
* estimated salary

Compensation at Tensha Therapeutics by Department

In Albuquerque, NM, The Finance Department averages $14,856 more than the Customer Support Department, and $19,683 less than the IT Department

IT
$99,933 Avg. total comp.
+$20k
Finance
$80,250 Avg. total comp.
Customer Support
$65,394 Avg. total comp.
-$15k

Director of Finance Compensation by Gender (All Companies)

The average female Director of Finance at companies similar size to Tensha Therapeutics reported making $176,135, while the average male Director of Finance at similar sized companies reported making $188,131.

Director of Finance Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Director of Finance at companies similar size to Tensha Therapeutics reported making $193,239, while the average Native American Director of Finance at similar sized companies reported making $145,000.

How Directors of Finance at Tensha Therapeutics Rate Their Compensation

100% say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at Tensha Therapeutics

×
Rate your company